Conference call
Murdoch says:
Patch has applications for other pain indications and partners
Oxyc was not the solution for a complex pain problem
Sub analysis supports theory of significant differences in patients and could work for a sub group (one sub group responded well)
Viable patch otherwise
Oxym progressing
Partner discussions ongoing and a priority as the trial ticked the platform box
0.7 cents at valued about 60% of cash backing.
Conference call Murdoch says: Patch has applications for other...
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(50.0%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $1.783K | 594.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 60 | 96365901 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 21872826 | 7 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |